Login to Complete an Application or to Access Judging Panel.
If you do not have an account, you can create one by clicking "My Account" or "Submit Now" in the navigation menu.
Foundation for Women's Cancer Diversity and Health Equity Research Grant
Research among diverse populations has demonstrated disparities in treatment outcomes, access to care, genetic testing rates, and disease survival across many diseases. This renewed Diversity and Health Equity Research Grant is a one-year project where the funding is available for two $75,000 Research grants.
The purpose of this award is to support research to understand and eliminate inequities in cancer care, specifically related to differential outcomes experienced by women from underserved or marginalized populations with gynecologic cancer, as well as to increase representation of underrepresented groups in gynecologic oncology as a strategy to achieve health equity for underserved women. Those eligible for applying are those who propose a study focused on a marginalized group, or those who identify as being from an under-represented group within the field of research.
This research would commence in April 2022, with a final report due on or before June 2023.
The Foundation’s Research Grants and Awards Committee, with the addition of two members from the SGO's Diversity, Inclusion and Health Equity Committee, will select the awardee.
The Winner will be announced at the 2022 SGO Annual Meeting on Women’s Cancer.
The applicant must be a member of the Society of Gynecologic Oncology, and their research must meet one of the following criteria:
- the applicant must self-identify as being from a race, ethnicity, gender identity, or sexual orientation historically underrepresented in cancer research**++, or
- their proposal must addresses gynecologic cancer topics including, but not limited to, access to care, therapeutic trials, and survivorship issues, among populations who are underserved or marginalized, based on their race, ethnicity, gender identity, sexual orientation or socioeconomic status.++
This year priority consideration will be given to proposals addressing health disparities in the context of gynecologic cancers related to the COVID-19 pandemic.
Lastly, the Foundation for Women's Cancer Research and Awards Committee, in addition to considering the strength of the research proposal and the factors indicated above, will also look at the benefit that receiving this grant would have on the applicant's career development.
**Please know that while you are not required to answer these questions in the portal, if your research does not directly address one of the topics listed above and you do not provide us with this information, your application for this grant may not be eligible.Additioanlly, please know that your responses will only be used by the Research and Awards Committee and otherwise kept private.
++Information on underrepresented groups as identified by the NIH can be found HERE, and underrepresented populations as subjects of research can be found HERE
- First you must answer qualifying questions to ensure you are eligible for this grant.
- A signed electronic application is required.
- A statement (100-500 words) describing the impact this grant would have on your career is required.
- An abstract that consists of a 250-word technical document for scientific review by the committee. Note that it should be written in a manner to allow a reviewer in translational gynecologic research to interpret the aims and methods. It is mandatory to include the author’s name and institution on the abstract.
- An updated CV is required.
- The signed application, CV and abstract should be submitted by Oct. 8, 2021 (before 11:59 p.m. Central Daylight Time)
Research Grant Full Proposals:
- The research grant proposal should include the principal investigator’s first name, last name and credentials in the upper right corner on all pages. The description of the research should be no longer than five (5) typed pages.First you mut answer qualifying questions to ensure you are eligible for this grant.
- The investigator’s bio sketch must be included. The bio sketch should state the total number of publications up to a maximum of 15.
- A budget, must be submitted along with a description of any other financial support.
- A short paragraph describing institutional support, career goals and how this grant would help the applicant achieve these goals is required with the full grant submission.
- A 250-word public abstract for donor review and press releases, using non-scientific terms, must be included in a Word document.
- The Foundation requires an interim report in a Word document of three to six paragraphs to describe progress to date. The interim report is due Oct. 2022. The final report is due July 2023.
- The signed application along with all of the components of the full proposal should submitted at or before 11:59 p.m. Central Daylight Time on Dec. 21, 2021
How to Apply
- Submit completed abstract application by Oct. 8, 2021.
- If selected, compete the full proposal portion of the research application portal at or before 11:59 p.m. Central Daylight Time on Dec. 21, 2021
- All applications must be in English.
Applications open Sept. 13th, 2021
The Foundation gratefully acknowledges GSK for their support of these grants